🔎 Trials Near Me

Home › Kidney Cancer (Renal Cell Carcinoma) › Michigan › Ann Arbor

Kidney Cancer (Renal Cell Carcinoma) clinical trials in Ann Arbor, MI

12 studies for Kidney Cancer (Renal Cell Carcinoma) are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · 7 mi away
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi away
  • and 4 more
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

RecruitingPhase 2
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · 7 mi away
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi away
  • and 4 more
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT03866382

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

RecruitingPhase 2
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • University of Michigan Rogel Cancer Center, Ann Arbor
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi away
  • and 4 more
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT05327686

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

RecruitingPhase 1
  • University of Michigan, Ann Arbor
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07195916

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

RecruitingPhase 3
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi away
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi away
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi away
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06661720

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

RecruitingPhase 1
  • University of Michigan, Ann Arbor
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT06966024

Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial

RecruitingPhase 1/2
  • University of Michigan Comprehensive Cancer Center, Ann Arbor
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06866262

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

RecruitingPhase 3
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi away
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi away
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi away
Ages 18 and older · All sexes · Updated Jun 11, 2026 · NCT07383441

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

RecruitingPhase 1
  • University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 252010, Ann Arbor
Ages 18 and older · All sexes · Updated Jun 4, 2026 · NCT04777994

Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

RecruitingPhase 2
  • University of Michigan, Ann Arbor
Ages 18 and older · All sexes · Updated May 20, 2026 · NCT06053658

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

RecruitingPhase 1
  • University of Michigan Hospitals, Ann Arbor
Ages 18 and older · All sexes · Updated Sep 23, 2025 · NCT06805825

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

RecruitingPhase 3
  • University of Michigan Comprehensive Cancer Center, Ann Arbor
  • University of Michigan - Brighton Center for Specialty Care, Brighton · 18 mi away
Ages 18 and older · All sexes · Updated Sep 9, 2025 · NCT04510597

Kidney Cancer (Renal Cell Carcinoma) trials in other cities

Other studies in Ann Arbor

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.